Covalon Technologies Price to Free Cash Flow Ratio 2013-2024 | CVALF

Covalon Technologies price to free cash flow ratio from 2013 to 2024. Price to free cash flow ratio can be defined as

Covalon Technologies Price to Free Cash Flow Ratio 2013-2024 | CVALF

Covalon Technologies price to free cash flow ratio from 2013 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$234.6B
Intuitive Surgical (ISRG)$174.6B
Alcon (ALC)$48.6B
IQVIA Holdings (IQV)$43.6B
IDEXX Laboratories (IDXX)$42.1B
Edwards Lifesciences (EW)$41.8B
DexCom (DXCM)$28.1B
STERIS (STE)$24B
SONOVA HOLDING (SONVY)$21.5B
Waters (WAT)$19.5B
Hologic (HOLX)$19.2B
Sysmex ADR (SSMXY)$12.3B
Fresenius Medical Care AG KGaA (FMS)$12.3B
Teleflex (TFX)$11.6B
Globus Medical (GMED)$9.5B
Penumbra (PEN)$7.3B
Glaukos (GKOS)$6.8B
Masimo (MASI)$6.1B
TransMedics (TMDX)$5B
Integer Holdings (ITGR)$4.3B
PROCEPT BioRobotics (PRCT)$4.3B
Tandem Diabetes Care (TNDM)$2.8B
Inari Medical (NARI)$2.7B
LivaNova (LIVN)$2.6B
Nihon Kohden (NHNKY)$2.6B
Veracyte (VCYT)$2.6B
Elekta AB (EKTAY)$2.4B
RxSight (RXST)$2.1B
Integra LifeSciences Holdings (IART)$1.3B
Pulse Biosciences (PLSE)$1.2B